{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-001941","form_type":"8-K","ticker":"LPCN","cik":"0001535955","company_name":"Lipocine Inc.","filed_at":"2022-01-21T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.907626+00:00","generated_at":"2026-06-27T16:29:39.075239+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Lipocine CFO Morgan Brown resigns effective Jan 31; Krista Fogarty appointed Principal Accounting Officer","bullets":["Morgan Brown resigns as EVP and CFO, effective Jan 31, 2022; no disagreement with company.","CEO Mahesh Patel will serve as interim Principal Financial Officer until successor is appointed.","Krista Fogarty, Corporate Controller, appointed Principal Accounting Officer effective Jan 19, 2022.","Fogarty has prior CFO and controller experience at biotech and pharma companies including NPS Pharmaceuticals."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-001941","json":"https://secwatch.observer/filing/0001493152-22-001941.json","markdown":"https://secwatch.observer/filing/0001493152-22-001941.md","text":"https://secwatch.observer/filing/0001493152-22-001941.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222001941/0001493152-22-001941-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222001941/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T16:29:39.075239+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"307e798b91","claim":"Morgan Brown resigned as Executive Vice President and Chief Financial Officer at Lipocine Inc..","evidence_excerpt":"On January 17, 2022, Morgan Brown provided Lipocine, Inc. (the “Company”) with notice of his intent to resign from his position as Executive Vice President and Chief Financial Officer of the Company, effective as of January 31, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222001941/0001493152-22-001941-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Executive Vice President and Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"60dd69e4e1","claim":"Mahesh Patel changed role as Principal Financial Officer at Lipocine Inc..","evidence_excerpt":"Upon the effective date of Mr. Brown’s resignation, Mahesh Patel, the Company’s President and Chief Executive Officer, will serve as the Company’s Principal Financial Officer on an interim basis until Mr. Brown’s successor is appointed.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222001941/0001493152-22-001941-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will serve as"},{"label":"Role","value":"Principal Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"b847dce279","claim":"Krista Fogarty was appointed as Principal Accounting Officer at Lipocine Inc..","evidence_excerpt":"On January 19, 2022, the Board of Directors of the Company appointed Krista Fogarty, the Company’s Corporate Controller, to also serve as the Principal Accounting Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222001941/0001493152-22-001941-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Principal Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}